Jack A. Khattar Salary and Compensation - SUPERNUS PHARMACEUTICALS, INC. CEO Salary 2025

In fiscal year 2025, Jack A. Khattar, Chief Executive Officer President & Secretary of SUPERNUS PHARMACEUTICALS, INC. (SUPN), received total compensation of $15.5 million.

Jack A. Khattar's compensation breakdown includes: base salary of $1.0 million, stock awards valued at $6.5 million, option awards of $7.0 million, non-equity incentive compensation of $847K, and other compensation of $52K.

Compared to fiscal year 2024, Jack A. Khattar's total compensation decreased 13% from $17.8 million to $15.5 million.

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Executive Pay 2025

SUPERNUS PHARMACEUTICALS, INC.'s top 5 named executive officers received combined total compensation of $21.6 million in fiscal year 2025.

The named executive officers disclosed in SUPERNUS PHARMACEUTICALS, INC.'s 2025 proxy statement are:Jack A. Khattar (Chief Executive Officer President & Secretary) with total compensation of $15.5 million, Timothy C. Dec (Senior Vice President Chief Financial Officer) with total compensation of $1.9 million, Jonathan Rubin (MD Senior Vice President, Chief Medical Officer Research and Development) with total compensation of $1.4 million, Padmanabh P. Bhatt (Ph.D. Senior Vice President, Intellectual Property, Chief Scientific Officer) with total compensation of $1.4 million, and Frank Mottola (Senior Vice President Chief Technical Operations Officer) with total compensation of $1.4 million.